S. Gulcan-Kersin Et Al. , "Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation," HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5, pp.313-321, 2020
Gulcan-Kersin, S. Et Al. 2020. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation. HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5 , 313-321.
Gulcan-Kersin, S., Kirkgoz, T., Eltan, M., Rzayev, T., Ata, P., Bilgen, H. S., ... Özek, E.(2020). Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation. HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5, 313-321.
Gulcan-Kersin, SİNEM Et Al. "Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation," HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5, 313-321, 2020
Gulcan-Kersin, SİNEM G. Et Al. "Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation." HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5, pp.313-321, 2020
Gulcan-Kersin, S. Et Al. (2020) . "Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation." HORMONE RESEARCH IN PAEDIATRICS , vol.93, no.5, pp.313-321.
@article{article, author={SİNEM GÜLCAN KERSİN Et Al. }, title={Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation}, journal={HORMONE RESEARCH IN PAEDIATRICS}, year=2020, pages={313-321} }